Investor notice: robbins llp informs stockholders of the class action lawsuit filed against applied therapeutics, inc.

San diego , dec. 19, 2024 /prnewswire/ -- robbins llp announces that a class action was filed on behalf of all investors who purchased or otherwise acquired applied therapeutics, inc. (nasdaq: aplt) securities between january 3, 2024 and december 2, 2024. applied therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases.
APLT Ratings Summary
APLT Quant Ranking